1)がんの統計編集委員会.Cancer statistics in Japan 2008.がん研究振興財団,2008
2)有馬美和子,神津照雄,小出義雄,他.表層拡大型食道表在癌の内視鏡診断─臨床病理学的検討と内視鏡診断の精度.胃と腸 30 : 1011-1020, 1995
3)Japan Esophageal Society. Japanese classification of esophageal cancer. Esophagus 7 : 7-22, 2009
4)門馬久美子,吉田操,山田義也,他.食道粘膜癌の内視鏡診断─深達度亜分類を用いた深達度診断の検討.胃と腸 29 : 327-340, 1994
5)日本食道学会(編).食道癌診断・治療ガイドライン,2012年4月版.金原出版,pp 14-18,2012
6)幕内博康,島田英雄,千野修,他.食道癌の初期病巣を発育進展─内視鏡の立場から.胃と腸 35 : 527-539, 2000
7)吉田操,門馬久美子,葉梨智子,他.発育進展からみた食道粘膜下層癌の病型分類の問題点.胃と腸 35 : 547-556, 2000
8)Yamashina T, Ishihara R, Uedo N, et al. Safety and curative ability of endoscopic submucosal dissection for superficial esophageal cancers at least 50mm in diameter. Dig Endosc 24 : 220-225, 2012
9)Hashimoto S, Kobayashi M, Takeuchi M, et al. The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection. Gastrointest Endosc 74 : 1389-1393, 2011
10)Yamaguchi N, Isomoto H, Nakayama T, et al. Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Gastrointest Endosc 73 : 1115-1121, 2011
11)Hanaoka N, Ishihara R, Takeuchi Y, et al. Intralesional steroid injection to prevent stricture after endoscopic submucosal dissection for esophageal cancer : a controlled prospective study. Endoscopy 44 : 1007-1011, 2012